• October 23, 2021

Converge Biotech Announces the Launch of Vergiflu (Favipiravir 200 mg) in India to Treat Mild to Moderate Covid-19

  • August 4, 2020

Converge Biotech Announces the Launch of Vergiflu (Favipiravir 200 mg) in India to Treat Mild to Moderate Covid-19

Hyderabad, August 04, 2020. Converge Biotech, a leading healthcare company based at Hyderabad, today announces the launch of generic Favipiravir tablet in India. It will be marketed under the brand name ‘VERGIFLU’ and is indicated for use in mild to moderate COVID-19 patients. Vergiflu is orally administered making it a…
Live Updates COVID-19 CASES